Company Presentation. October 2013

Transcription

1 Company Presentation October 2013

2 Medivo Utilizes Lab Data to Improve Health Medivo finds my patients, reaches out to them, and makes sure they have the right lipid panel information so that when they come in to see me, I can make the best treatment decisions for them. Dr. Safirstein, Cardiologist from New Jersey Our Data Analytics and Intervention Platform Helps: Physicians and Payers to track and improve patient outcomes: population-based & detailed Patients to monitor their health via tools and clinical insights Life science clients to target, measure and message to increase Rx

3 Overview: Snapshot Located in Founded in 2010 ARC, Esther Dyson $15M Series B June 2013 $7M Series A Late 2011 $750K Angel Round 2010 HIPAA Compliant Private Cloud Analytics Platform SSAE 16 II Certified Key Clients Life Sciences Cos Health plans Key Partners Clinical Labs Providers

4 Overview: Our People Key Employees

5 Why Lab Data Analytics? Drives 70% of clinical decisions Growing role of companion diagnostics in therapy selection Empowers consumers Testing is 50%-60% underutilized due to gaps in care Lab market is extremely fragmented Comprises 2% of overall healthcare costs Great measure of quality and outcomes Convergence of diagnostics and therapeutics

6 In Billions Overview: Market Opportunity U.S Pharma Marketing Healthcare Analytics (in Billions) The healthcare analytics market is estimated to grow at 23.7% from 2012 to 2017 to reach $10.8 billion Referenced from Forrester Research, etc. 1 Source RNR Market Research

7 Medivo Lab Value Exchange Medivo Lab Value Exchange 3,500 Practices >15K Providers Data Aggregation and Harmonization 3M+ Patients Life Science Companies Payers Data Sources National, Regional, Specialty labs >100 labs Labs

8 Medivo Lab Data Analytics Platform Clinical Alerts & Messaging Proprietary algorithms to identify care gaps. Analytics engine to drive improvement in care. Lab Results Search Utility Search appliance for direct access to patient lab results across multiple platforms. Google search of lab results. Data Aggregation & Harmonization 2012 Referenced from Forrester Research, etc. Ability to aggregate and normalize lab data from multiple sources. Experts in all things lab data.

9 Building the Ubiquitous Lab Search Utility

10 Platform: Provider Satisfaction with Medivo Keep up the great work, and thank you for making my patient care and disease tracking a lot easier The information provided by Medivo is very valuable

11 Medivo Targeted Provider Growth Provider acquisition cost < $100

12 Growth in Identified Patients w/clinical Data 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 65OVER UNDER 0%

13 Platform: Lab Data Access for Patients

14 Revenue: Clinical Data and Analytics Diabetes Patient Identification Algorithm An May Include aly ze Dx Code: T2DM > 2 HgA1c in 12 months = Diabetic HgA1c > 7.0 & > 3 months = Gap Fasting Glucose > 127 & no HgA1c = Gap Random Glucose > 200 & no HgA1c = Gap 200K Physicians >50M Patients

15 Medivo Revenue Model

16 Financials: P&L and Bookings Projections ($'s in 000's) Actual Projected - Year Ended Decem ber 31, Clinical data, analytics, & messaging 184 1,815 5,107 9,353 23,745 41,943 60,179 Clinical services 2,414 2,832 3,336 4,243 7,406 14,601 26,872 Total Revenues 2,598 4,647 8,442 13,596 31,151 56,544 87,051 Direct cost of sales 517 1,642 3,302 5,700 9,554 15,932 24,006 Gross profit 2,081 3,005 5,140 7,896 21,597 40,611 63,045 Operating expenses Research & development 284 1,040 1,997 3,573 4,413 5,090 5,784 Sales & marketing 1,012 2,502 3,167 4,996 7,583 10,776 13,561 Operations ,391 5,503 7,097 8,502 9,779 General & administrative 1,567 2,172 2,729 3,265 4,057 4,682 5,297 Total operating expense 3,133 6,587 11,284 17,337 23,151 29,050 34,421 EBITDA (1,052) (3,583) (6,143) (9,441) (1,554) 11,561 28,624 Bookings 4,966 7,203 9,107 20,452 44,672 69, ,552

17 Strategy: Expansion Data Sources/Patient Growth 25M 50M 75M 100M EHRs Pilots Top EHRs Rx / Claims Data Surescripts Emdeon National Pharmacies HIEs Regional Pharmacies Apps/Devices Medivo Apps Third Party Apps Quantified Self Apps/Devices Healthcare Data Layer Lab Connectivity National Select Regionals Additional Hubs Specialty Additional Specialty Hubs

18 Market Analysis Comparisons Focused on Acquired by Medicity HIE Solutions Aetna for $500M Axolotl HIE Solutions Ingenix for around $140M (8X Revs) dbmotion Data Analytics Allscripts for $235M Humedica Data Analytics UnitedHealth (optum) $ M

19 Conclusion Proven Leadership Team Strong leadership team with a track record Strategic and medical advisors add extensive health care and data analytics experience Industry access and credibility Proven Business Model Proven and tested products Proven sales through key clients Strong revenue model Great Opportunity to Build Value Large market opportunity of >$15 billion Well positioned for fast growth, right services at right time 2-3% share can lead to $300 million to $500 million in revenues

20 THANK YOU!

21 Appendix

22 Building the Largest Lab Data Repository National, Regional, State Product/ Account Sales Force Aligned Ordering Account Provider Specialty Provider State and Zip Practice Size (where appropriate) Patient Demographics Payer (Medicare, Medicaid, Commercial) Test gaps & anomalies Test Name Test Number Diagnostic Codes (ICD9) Normal Lab Range Lab Result (incl. code or symbol for abnormal results) Lab Test Service Date